|
Siegler, Richard L; Pysher, Theodore J; Tesh, Vernon L et al. (2005) Reduced nitric oxide bioavailability in a baboon model of Shiga toxin mediated hemolytic uremic syndrome (HUS). Ren Fail 27:635-41
|
|
Clayton, Frederic; Pysher, Theodore J; Lou, Randall et al. (2005) Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol 25:536-40
|
|
Siegler, Richard L; Obrig, Tom G; Pysher, Theodore J et al. (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92-6
|
|
Pysher, Theodore J; Siegler, Richard L; Tesh, Vernon L et al. (2002) von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome. Pediatr Dev Pathol 5:472-9
|
|
Siegler, Richard L; Pysher, Theodore J; Tesh, Vernon L et al. (2002) Renal prostacyclin biosynthesis in a baboon model of Shiga toxin mediated hemolytic uremic syndrome. Nephron 92:363-8
|
|
Andreoli, Sharon P; Trachtman, Howard; Acheson, David W K et al. (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17:293-8
|
|
Siegler, Richard L; Pysher, Theodore J; Tesh, Vernon L et al. (2002) Prophylactic heparinization is ineffective in a primate model of hemolytic uremic syndrome. Pediatr Nephrol 17:1053-8
|
|
Siegler, R L; Pysher, T J; Lou, R et al. (2001) Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome. Am J Nephrol 21:420-5
|
|
Siegler, R L; Pysher, T J; Tesh, V L et al. (2001) Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J Am Soc Nephrol 12:1458-67
|
|
Taylor Jr, F B; Tesh, V L; DeBault, L et al. (1999) Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285-99
|
